<DOC>
	<DOCNO>NCT02691351</DOCNO>
	<brief_summary>The good understanding non-Hodgkin T-cell lymphoma essential establish effective treatment strategy non-Hodgkin T-cell lymphoma . Therefore , data conical feature treatment outcomes subtype accumulated establish treatment strategy . However , majority previous data non-Hodgkin T-cell lymphoma small case series single institute . Furthermore , novel drug develop treatment relapsed refractory T-cell lymphoma , date patient treat novel drug especially require outcome may reflect outcome currently available treatment . Thus , multinational , multicenter prospective registry study need provide information useful establish treatment strategy T-cell lymphoma .</brief_summary>
	<brief_title>Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<criteria>Pathologically diagnosed Mature Tcell nonHodgkin lymphoma base World Health Organization classification 2008 Newly diagnose patient without previous treatment history Tcell lymphoma relapsed/refractory Tcell lymphoma patient Age â‰¥19 year Written inform consent Hodgkin lymphoma nonHodgkin Bcell lymphoma Immature nonHodgkin Tcell lymphoma : Precursor Tlymphoblastic lymphoma/leukemia Not understand inform consent</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>